Market Tracker

02/27 6:02pm ET

Incyte Corp (NASDAQ:INCY)

85.85
Delayed Data
As of Feb 27
 -1.69 / -1.93%
Today’s Change
40.30
Today|||52-Week Range
88.44
+17.43%
Year-to-Date

Today’s Trading

Previous close87.54
Today’s open87.01
Day’s range84.23 - 87.60
Volume917,065
Average volume (3 months)1,158,359
Market cap$14.7B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+13.07%
Earnings growth (next 5 years)+209.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...+0.36+0.42%
HSPHospira Inc0.000.00%
MNKMallinckrodt Plc-2.89-2.42%
PCYCPharmacyclics Inc-1.89-0.87%
Data as of 4:14pm ET, 02/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts